The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ablative therapy to induce local and systemic immune changes in patients with metastatic renal cell carcinoma.
 
Matthew T. Campbell
Consulting or Advisory Role - Eisai
 
Surena F. Matin
Consulting or Advisory Role - Theracoat; Tokai Pharmaceuticals
Research Funding - AT&T
 
Rebecca Slack
No Relationships to Disclose
 
Jing Jing Sun
No Relationships to Disclose
 
Derek Ng Tang
No Relationships to Disclose
 
Hong Chen
No Relationships to Disclose
 
Jorge M Blando
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Priya Rao
No Relationships to Disclose
 
Padmanee Sharma
Leadership - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Neon Therapeutics (I); SAB-Pharma; SAB-Pharma (I)
Stock and Other Ownership Interests - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)